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Abstract 
Objectives: Whether or not the cardio-protective effect of β-adrenergic 
blockade is retained during resistance exercise has not been systematically 
evaluated. Therefore the purpose of this study was to measure selected 
cardiorespiratory responses to isometric exercise involving hand-gripping, 
single-leg extension, or double-leg dead-lift, under placebo (control), β1-
selective (atenolol), and non-selective (propranolol) adrenergic blockade 
conditions. 
Design: Eleven young male adults were evaluated in a randomized, double-
blinded, repeated measures study design and performed all three exercise 
modalities at 30% of maximal voluntary contraction under placebo, atenolol 
and propranolol conditions. 
Methods: Heart rate, systolic and diastolic blood pressure, rate-pressure 
product, oxygen uptake, cardiac output, stroke volume and total peripheral 
resistance were directly measured or calculated at rest and during the third 
minute of each of the three exercise modes. 
Results: Irrespective of drug condition, a graded pressor response was 
observed going from rest to exercise so that rest < handgrip < leg 
extension < dead-lift for heart rate, systolic and diastolic blood pressures, 
rate-pressure product and oxygen uptake (p < 0.05 for all). Cardiac output 
only increased with the dead-lift mode of exercise (p < 0.01). Importantly β-
adrenergic blockade with either atenolol or propranolol similarly attenuated 
the rise in heart rate, and systolic blood pressure; thus rate-pressure product 
demonstrated a mode-of-exercise by drug interaction effect (p < 0.001) with 
the greatest reductions seen with the dead-lift procedure. 
Conclusions: The findings indicate that cardio-protection afforded by 
selective or non-selective β-blockade at rest is preserved during isometric 
exercise and even enhanced once heart rate increases above 
100 beats min−1. 
Keywords: Rate-pressure product; Myocardial oxygen consumption; Pressor 
response; Isometric muscle contractions 
1. Introduction 
The hemodynamic response to static or resistance exercise 
differs considerably from that to dynamic exercise. Increases in heart 
rate, stroke volume, and skeletal muscle blood flow are the hallmarks 
of dynamic exercise, while an increase in blood pressure is the 
signature of isometric-like muscular contractions, the so-called 
“pressor” response.1 
It is recognized that both types of exercise can increase the 
heart's requirement for oxygen (MvvO2). The principal factors affecting 
MvvO2 are heart rate (HR) and blood pressure, so that the product of 
HR and systolic blood pressure (SBP), or rate pressure product (RPP) 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Science and Medicine in Sport, Vol. 20, No. 2 (February 2017): pg. 196-201. DOI. This article is © Sports 
Medicine Australia, published by Elsevier Ltd. and permission has been granted for this version to appear in e-
Publications@Marquette. Sports Medicine Australia, published by Elsevier Ltd.does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Sports Medicine Australia, 
published by Elsevier Ltd.. 
3 
 
correlates strongly with MvvO2 measured during exercise whether it be 
dynamic, static or a combination of both.2 Beta-adrenergic blockade 
that lowers MvvO2 through its effects on both HR and blood pressure is 
a common pharmacological intervention for a variety of populations 
including individuals with angina, arrhythmias, hypertension, and 
migraines as well as post-myocardial infarction patients.3, 4 and 5 
However the response to static exercise involving muscle mass of 
different sizes while simultaneously undergoing selective β1- or non-
selective β1, β2-adrenergic blockade has not been systematically 
characterized. 
Therefore the purpose of this study was to measure the 
hemodynamic and metabolic responses to static exercise involving 
three different-sized muscle masses under placebo (control), and β-
adrenergic blockade conditions. In this manner we sought to 
determine whether the cardio-protective effect of β-blockade is 
preserved during static exercise. We also sought to ascertain whether 
difference in responses observed were muscle-mass and/or cardio-
selective vs. non-selective blockade dependent. 
2. Methods 
Eleven male volunteers ranging in age from 19 to 28 yr, with a 
height of 175 ± 3 cm, and a body mass of 71 ± 2 kg served as 
participants for the study. All participants were non-smokers, were not 
taking any medications, and while active, had not engaged in training 
for competitive sports, or in a regimen of strength training for six 
months prior to the start of the study. Signed informed consent for all 
procedures was obtained in accordance with standards established by 
the University of Wisconsin-Madison Human Subjects Committee. 
Subjects reported to the laboratory at the same time of day for 
each test, having been given written and verbal reminders not to 
participate in any form of exercise or to consume stimulants or alcohol 
within the previous 24 h. On the initial visit to the laboratory (Visit 1, 
Fig. 1), oxygen consumption (vvO2) and electrocardiographic patterns 
(EKG; CM5 lead configuration) were measured on subjects while they 
performed a graded cycle ergometer test to volitional fatigue. The test 
protocol included 3 min of warm-up at 75 W followed by an initial 
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workload of 100 W for 2 min. The resistance was subsequently 
increased by 50 W every 2 min until the point of exhaustion which was 
defined as inability to hold the required cadence of 60 ± 10 revolutions 
per minute (RPM) at the highest workload attained. This cycle test also 
elicited a vvO2max of 49 ± 2 ml kg−1 min−1 from the eleven 
participants. Individual final workload achieved on the incremental 
cycle ergometer test was used to determine the submaximal constant 
workload which was set at 65% of the previously attained maximal 
workload. Two days later subjects returned to the laboratory (Visit 2) 
and following a warm-up consisting of pedaling at 75 W for 3 min, 
cycled at a resistance corresponding to 65% of individual maximal 
workload until a steady-state was achieved, as indicated by less than a 
5 beats min−1 increase in HR during a 60 s period. Subsequently all 
subjects repeated the submaximal constant workload test under 
placebo (Visits 3a to 6a), propranolol (Visits 3b to 6b) and atenolol 
(Visits 3c to 6c) conditions (see Fig. 1). 
 
Fig. 1. Protocol schematic of exercise testing, β-blockade titration algorithm, and main 
study. During the titration phase, all participants took part in four visits while on 
placebo regardless of lack of change in HR plateau between visits in an effort to blind 
them from their treatment. 
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The β1-selective (atenolol, (ATEN)) or non-selective β-blocker 
(propranolol, (PROP)) as well as a placebo pill were randomly 
administered in a double-blind fashion and doses of the two β-blockers 
were individually titrated according to each individual's HR response to 
the submaximal workload (see below). Initially all subjects took either 
placebo, PROP (80 mg), or ATEN (50 mg) for a period of three days, 
and reductions in HR caused by non-selective or selective blockade 
during the constant workload test were measured. Three days later 
subjects returned to repeat the same cycle ergometer test with doses 
of the two β-blockers increased to 160 mg and 100 mg, respectively. 
If no further reduction in HR was observed with the higher dose in a 
particular subject, the initial dosage of either PROP or ATEN was used 
for that subject. However if the higher dose caused a further reduction 
in HR (>5 beats min−1) a higher dose of PROP (240 mg) and ATEN 
(150 mg) was administered for three days and the test repeated a 
second time. This routine was repeated until the individual HR 
response to the 65% maximal workload test decreased less than 
5 beats min−1 from the previous test. As anticipated, placebo 
administration did not affect HR response to the 65% workload test 
(Fig. 1). 
Completion of the titration experiments indicated that, for PROP, 
four of the 11 subjects achieved complete blockade taking 
80 mg day−1, four achieved it with 160 mg day−1, with the remaining 
three requiring 240 mg day−1. For ATEN, three of the subjects 
demonstrated a HR plateau with the lowest dose (50 mg day−1), 6 
subjects required the intermediate dose (100 mg day−1), and two 
subjects required 150 mg day−1 (Fig. 2). As also shown in Fig. 2, 
titration of the mean HR response of all 11 subjects to PROP resulted 
in a significant 20 beats min−1 reduction in HR (143 to 
123 beats min−1) going from the un-medicated state to 80 mg day−1 
(p < 0.005), while treatments of 160 and 240 mg day−1 did not result 
in further significant decreases in HR. For ATEN, mean HR reductions 
were observed going from the un-medicated state to 50 mg day−1 
(142 to 119 beats min−1, p < 0.005), and from 50 to 100 mg day−1 
(119 to 110 beats min−1; p < 0.05), but not from 100 to 
150 mg day−1. During the main study (see below) a seven day wash-
out period was employed between each of the three experimental 
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sessions to ensure that all β-blockers were completely metabolized 
prior to commencement of the subsequent experimental session. 
 
Fig. 2. Mean titration curves (n = 11 subjects) in response to placebo, propranolol 
(PROP) and atenolol (ATEN) β-blockade while cycling on an ergometer at 65% 
individual maximal workload. For PROP, 80 mg day−1 resulted in a significant HR 
reduction from the un-medicated state (**, p < 0.005), with no further reduction in 
HR seen with 160 or 240 mg day−1. For ATEN, 50 mg day−1 resulted in a significant HR 
reduction from the un-medicated state (**, p < 0.005), with a further reduction (*, 
p < 0.05) seen going from 50 to 100 mg day−1, but not from 100 to 150 mg day−1. 
The main study involved three identical experimental sessions. 
Three days prior to each session, subjects self-administered their 
individually-titrated dose of one of the two β-blockers (or placebo). 
The last dose was taken at least 3 h, but not more than 6 h prior to 
arrival at the laboratory. During each visit to the laboratory subjects 
performed a maximal voluntary contraction (MVC) for one-arm 
handgrip (HG), single-leg extension (LE), and double-leg dead-lift, 
(DL). Based on these values, subjects subsequently maintained 30% 
of MVC for 3 min while performing each of the three types of static 
contractions. 30% MVC was choosen to allow time to collect all of the 
required parameters of interest (see below) and also because this 
intensity had been used previously in the literature to study the 
exercise pressor response.6, 7 and 8 
Hand-gripping was carried out using a calibrated Stoelting 
dynamometer adapted so that tension exerted during contraction was 
displayed on a dual beam oscilloscope (Portland, OR) and a LCD digital 
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Ohm multimeter (Radio Shack, Fort Worth, Texas). The left arm was 
supported by a small metal tray to reduce extraneous muscular effort. 
Single-leg extension was performed on a padded table on which strain 
gauges had been mounted to a steel bar secured to the legs of the 
table. The subject was secured by a seat belt. The angle of the knee 
joint was set at 70 degrees prior to full extension to facilitate tension 
production in this maneuver. The strain gauges were calibrated with 
known weights at the angle at which force was generated (70 degrees) 
and was linear within the range studied. The DL maneuver involved 
outfitting the subject with a modified parachute harness in a semi-
squat position. Subject angle at the knee was set at 70 degrees, with 
the trunk, shoulders and back extending vertically up through the 
harness. The subject was connected to a wooden platform specifically 
designed to hold the steel bar strain gauge previously described for LE. 
During this maneuver the subject utilized both trunk and lower limb, 
but not upper limb muscles. This permitted blood pressure 
measurements to be made on the upper extremity. The 30% MVC 
force being maintained by each subject during the three minute period 
for HG, LE and DL under each condition (placebo, PROP, ATEN) was 
observed on the oscilloscope, and a digital readout provided visual 
reinforcement of the constant tension required. 
The parameters of HR, SBP, DBP, RPP, vvO2, carbon dioxide 
production (vvCO2), cardiac output ( Q˙), stroke volume (SV), and 
total peripheral resistance (TPR), were obtained either directly or by 
calculation, both at rest and during 30% MVC for the three modes of 
exercise.vvO2 and vvCO2 were calculated using a Beckman E2 gas 
analyzer and a Godart Capnograph, respectively calibrated with 
standard gases verified by Scholander analysis, as reported previously 
during isometric exercise.6 SBP and DBP were obtained with a Puritan 
Bennett Infrasonde Model 04000 electronic blood pressure monitor. 
Measurements taken in this manner had previously been validated 
against intra-arterial pressures obtained under similar experimental 
conditions.9 Cardiac output (?̇?) was determined using the CO2 
rebreathing technique as described by Jones and Campbell10 as 
employed previously during static exercise.7 
The measured ?̇? was divided by the recorded HR to obtain SV. 
Mean arterial blood pressure (MABP) was calculated from the 
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measured SBP and DBP (MABP = DBP + (SBP − DBP)/3). This 
calculation then permitted the additional calculation of TPR from MABP 
divided by ?̇?. 
Data were analyzed by a two-way repeated measures analysis 
of variance (ANOVA) for exercise and drug main effects as well as for 
interactions. Post-hoc contrasts to determine differences between 
means were carried out when appropriate, with α set at p < 0.05. 
3. Results 
Neither selective (β1) nor non-selective (β1,2)-adrenergic 
blockade significantly affected maximal tension development (and 
consequently 30% MVC) for HG, LE and DL as shown in Table 1 
expressed in Newtons (N). This permitted evaluation of the effects of 
ATEN and PROP on hemodynamic and metabolic responses to these 
same three modes of isometric exercise that was not compounded by 
differences in force development between the three treatment 
conditions. 
Table 1. Heart rate (HR) measured at rest, and at 30% MVC (Newtons (N)) for 
handgrip (HG), single-leg extension (LE) and double-leg dead-lift (DL), measured 
under placebo, propranolol (PROP) and atenolol (ATEN) conditions. 
 
Condition Parameter Placeboa PROPa ATENa 
Rest HR (beats min−1) 65 ± 2 54 ± 2b 53 ± 3c 
HG 
HR (beats min−1) 77 ± 3 67 ± 4b 63 ± 4c 
30% MVC (N) 128 128 137 
LE 
HR (beats min−1) 87 ± 2 73 ± 3c 72 ± 3c 
30% MVC (N) 128 118 128 
DL 
HR (beats min−1) 115 ± 6 88 ± 3c 88 ± 4c 
30% MVC (N) 588 579 598 
a Within a treatment condition (placebo, PROP, ATEN) HR increased significantly going 
from rest to HG to LE to DL (all p < 0.05 or greater, except for HG to LE under PROP 
conditions (p < 0.06). 
b p < 0.005 versus placebo for rest or exercise mode (HG,). 
c p < 0.001 versus placebo for rest or exercise mode (LE, HG, DL). 
As also indicated in Table 1, HR increased significantly 
(p < 0.005) going from rest to HG to LE to DL, with the single 
exception of HG to LE under the PROP condition (p < 0.06). However 
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there was also a significant overall drug by mode-of-exercise 
interaction (p < 0.001). The HR lowering effects of both β-blockers 
were most pronounced with the largest contracting muscle mass (DL). 
Both ATEN and PROP caused a significant and identical 24% reduction 
in HR during DL compared to reductions seen either at rest or during 
the other two modes of exercise modalities ranging from 13 to 18%. 
As shown in Fig. 3, Panel A, all three modes of isometric 
exercise incrementally increased SBP above rest so that 
rest < HG < LE < DL (all p < 0.005). Both ATEN and PROP resulted in 
similar overall reductions (p < 0.05) in SBP compared to the placebo 
condition. In contrast to their effects on HR, there was no interaction 
effect so that the resting reductions in SBP caused by both β-blockers 
were similar to those seen during all three exercise modes. Increases 
in muscle mass involvement during exercise caused incremental and 
significant increases in DBP under all three drug conditions, so that 
rest < HG < LE < DL (all p < 0.05). Compared to the placebo 
condition, while both PROP and ATEN lowered DBP at rest and during 
HG, LE, and DL, only the reductions seen with ATEN were significant 
(p < 0.05). 
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Fig. 3. Panels A–F indicate systolic and diastolic blood pressure (SBP, DBP), rate-
pressure product, vvO2, cardiac output, stroke volume, and total peripheral resistance 
at rest, and during hand-grip (HG), leg-extension (LE) and dead-lift (DL) exercise 
under placebo (control), propranolol (PROP) and atenolol (ATEN) conditions. A 
significant overall exercise main effect is indicated by * (p < 0.05 or greater); a 
significant overall exercise mode-by-drug interaction effect is indicated by † 
(p < 0.001). Significant differences in PROP or ATEN from placebo (p < 0.05 or 
greater), either at rest, or during HG, LE and DL are indicated by P (propranolol) or A 
(atenolol). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Science and Medicine in Sport, Vol. 20, No. 2 (February 2017): pg. 196-201. DOI. This article is © Sports 
Medicine Australia, published by Elsevier Ltd. and permission has been granted for this version to appear in e-
Publications@Marquette. Sports Medicine Australia, published by Elsevier Ltd.does not grant permission for this article to 
be further copied/distributed or hosted elsewhere without the express permission from Sports Medicine Australia, 
published by Elsevier Ltd.. 
11 
 
RPP showed a significant mode-of-exercise by drug interaction 
(p < 0.001) similar to that observed above for HR, so that the effects 
of either ATEN or PROP on estimated MvvO2 were more pronounced 
with the largest contracting muscle mass (DL) causing a greater 
relative reduction in RPP compared to reductions seen at rest or 
employing smaller muscle masses (Fig. 3, Panel B). Again 
rest < HG < LE < DL (all p < 0.05) irrespective of drug condition, with 
both β-blockers causing significant RPP reductions during all three 
modes of exercise (p < 0.05), while only ATEN caused a significant 
reduction at rest (p < 0.05). 
Fig. 3, Panel C also indicates that going from rest to HG exercise 
resulted in a significant increase in vvO2 (p < 0.05); each subsequent 
mode of exercise involving more muscle mass caused a further 
increment in vvO2 compared to the previous one so that 
rest < HG < LE < DL (p < 0.005 for exercise mode comparisons). 
PROP but not ATEN caused a significant reduction (p < 0.005) in vvO2 
during all three exercise modes but not at rest. 
Cardiac output (?̇?) increased slightly above resting with HG and 
LE, but only the increase seen with DL was significant (p < 0.001, Fig. 
3, Panel D). Cardiac output (?̇?) during DL was also significantly higher 
than with either HG or LE (both p < 0.001). Propranolol (PROP) but 
not ATEN caused a significant reduction (p < 0.01) in ?̇? both at rest 
and during all three modes of exercise. The exercise-induced increase 
in ?̇? was achieved solely by increasing HR as SV decreased from rest 
to HG (p < 0.05), but did not decrease further going from HG to LE or 
to DL (Fig. 3, Panel E). 
Handgrip (HG) exercise caused an increase (p < 0.05) in TPR 
above resting, with no further increment seen for LE or DL (Fig. 3, 
Panel F). There was also a trend (p < 0.1) for PROP but not ATEN to 
elevate TPR compared to the placebo condition but this was not 
significant. 
4. Discussion 
The main purpose of the current study was to determine 
whether β-adrenergic blockade altered hemodynamic and metabolic 
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responses to isometric exercise involving small, medium and large 
muscle masses, and also whether differences could be discerned 
between cardio-selective vs. non-selective β-blockade. The main 
finding from this study was that the cardio-protective effect of β-
adrenergic blockade is maintained during isometric exercise involving 
muscle mass of contrasting sizes at least when this musculature is 
developing only 30% of its maximal potential force. Thus RPP as a 
non-invasive measure of MvvO2 was significantly lower during HG, LE 
and DL with either PROP or ATEN with no obvious advantage of the 
cardio-selective vs. non-selective blocker. Furthermore this protection 
appears to be enhanced with the largest contracting muscle mass (i.e., 
DL) as indicated by the overall mode of exercise-drug interaction 
effect. This was presumably due to the more pronounced β-blockade 
effects on HR once HR rose above 100 beats min−1, as occurred with 
the DL maneuver, where HR increase is thought to be primarily due to 
sympathetic stimulation.8 
β-adrenergic blockade did not however prevent the pressor 
response classically seen with resistive exercise so that for both SBP 
and DBP there were incremental and significant increases going from 
rest to HG to LE to DL; pulse pressure thus remained fairly constant 
under placebo, PROP and ATEN conditions. While both β-adrenergic 
blockers had a similar lowering effect on SBP, the overall lower DBP 
seen with ATEN supports the tenet that selectivity of β-adrenoreceptor 
blockade was maintained with the doses of ATEN employed in the 
current study. The highest blood pressures (both SBP and DBP) were 
seen with the greatest amount of musculature involved (DL) under the 
three conditions. As TPR remained unchanged for HG, LE or DL, the 
increased ?̇? observed only with DL was achieved by an increase in HR, 
as SV during all three modes of exercise also remained relatively 
constant. The reduction in SV going from rest to HG exercise seen in 
the current study was also observed previously in older but not young 
men during hand-gripping.11 This reduction in SV in response to 
isometric exercise was also observed previously with LE.7 The 
tendency for TPR to be higher with PROP in the current study may also 
explain the lower ?̇? observed both at rest and during HG exercise 
under non-selective blockade as was also seen in a previous study.12 
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The findings from the current study also add to the body of 
literature as to whether or not the magnitude of the pressor response 
to isometric exercise is dependent on the size of the contracting 
muscle mass and specifically how this response might be affected by 
both β1- and β1,2-blockade. Earlier studies13, 14 and 15 reported no 
significant relationship between size of actively contracting muscle 
mass and magnitude of the cardiovascular response to isometric 
contractions when percent of MVC was held constant. In contrast, 
more recent studies16, 17 and 18 reported a direct relationship, providing 
evidence for a greater cardiovascular response to static contractions 
when progressively larger muscle groups were utilized. The overall 
response of HR, , SBP, DBP, and vvO2 to the recruitment of 
increasing muscle mass observed in the current study would support 
the concept of muscle size-dependent hemodynamic and metabolic 
responses to isometric exercise, even though this response was 
modified somewhat by both β-blockers. Thus the similar reductions in 
HR induced by PROP and ATEN both at rest and during exercise 
resulted in a lower overall  with PROP but not ATEN. An elevated SV 
compensated for the reduced HR under ATEN but not PROP conditions 
in an attempt to maintain . This difference appeared to be due to the 
trend towards higher overall vascular resistance with non-selective β-
blockade as might be expected. 
In the current study the metabolic cost of performing the 
various exercises as measured by vvO2 was also impacted by β-
adrenergic blockade. While vvO2 was increased going from rest to 
exercise (p < 0.05), but more so going from HG to LE (p < 0.005), 
and from LE to DL (p < 0.001), PROP caused significant reductions in 
vvO2 during all three exercise modes that may be related to the 
simultaneous reductions observed in Q˙ under non-selective 
blockade. This finding would again support the hypothesis that under 
somewhat more peripherally vasoconstricted conditions induced by 
non-selective β-blockade, additional reductions in blood flow delivery 
to working muscle could impact vvO2 and rate of fatigue. 19 and 20 
The similar force exerted under placebo, PROP and ATEN 
conditions for the three exercise modalities in the current study was 
not evaluated out to the point of task failure to assess whether non-
selective blockade reduced the time that this force could be 
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maintained. Interestingly, in the study of Unsworth et al.20 they 
compared maximal force (100% MVC) both before and after 3 min of 
sustained LE at 30% MVC under placebo, metoprolol and propranolol 
conditions (same recorded absolute force). The second 100% MVC 
contraction showed a greater reduction under propranolol compared to 
either metoprolol or placebo conditions, which did not differ from each 
other. The results from their study imply that peripheral blockade of β2 
receptors may result in additional constraints to blood flow to working 
muscle at least at 30% MVC. 
A limitation of the current study was that we did not image or 
use other techniques to directly measure size of contracting muscle 
mass in these experiments. Nevertheless, we purposely chose muscle 
groups contrasting in size, consistent with those employed in previous 
studies.6 and 10 
5. Conclusion 
From a clinical perspective, β1-selective adrenergic blockers are 
prescribed for cardiac patients more often than non-selective blockers. 
However the latter category of drugs would appear to be associated 
with a lower risk of thrombo-embolic events in heart-failure patients,21 
and therefore the findings from the current study that non-selective 
and selective β-blockade are no different with respect to their cardio-
protective effect during submaximal isometric exercise as estimated 
from RPP is also relevant. 
Practical implications 
• A class of drugs known as β-adrenergic blockers are commonly 
taken to lower heart rate and blood pressure. 
• In this manner these drugs lower oxygen requirements of the 
heart thus providing cardio-protection. 
• This protection is maintained during submaximal static exercise 
such as weight lifting. 
• Earlier fatigue is a potential outcome for an individual 
performing resistance exercise while on a non-selective β-
blocker. 
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